Nephrology News

Although recent clinical data continue to expand possible treatment options for lupus nephritis, whether belimumab or voclosporin should be the first-line therapy remained hotly contested during the ACR’s annual Great Debate.

Panelists opened 2021 ASN Kidney Week by discussing the impact that the COVID-19 virus can have on chronic kidney disease, in addition to how vaccinating vulnerable populations is the best way to end the pandemic.

Many misconceptions about the ketogenic diet are spread on the internet, an expert told attendees at the Obesity Medicine Association fall conference.

Researchers comparing patients on dialysis with and those without prostate cancer found the cancer increased risk for mortality and reduced the likelihood of transplant, even though transplantation improved survival by 80% for all patients.

Finding that patients in underrepresented groups had similar or better kidney care than white patients, researchers contended differences in care delivery cannot explain observed racial and ethnic disparities in disease progression.

Research from Kaiser Permanente supports the use of cystatin C tests as an alternative to creatinine-based tests for accurately assessing kidney function without the inclusion of race.

A joint task force of the National Kidney Foundation and the American Society of Nephrology has released its final report on considering race in diagnosing kidney disease and called for immediate adoption of race-free eGFR equations.

Following studies showing the benefits of finerenone for patients with chronic kidney disease and type 2 diabetes, Bayer announced it will now investigate the efficacy of the drug for delaying CKD progression in patients without diabetes.

Children and young adults with kidney disease showed a “high burden” of subclinical cardiovascular disease, according to a study that examined structural and functional abnormalities.

A speaker at the American Nephrology Nurses Association’s Nephrology Nursing Practice, Management & Leadership Conference discussed the development of AKI in patients who have hepatorenal syndrome or who use acetaminophen therapies.